| A gain-of-function mutation of JAK2 in myeloproliferative disorders R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg, ... New England Journal of Medicine 352 (17), 1779-1790, 2005 | 4781 | 2005 |
| Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors A Egli, L Infanti, A Dumoulin, A Buser, J Samaridis, C Stebler, R Gosert, ... The Journal of infectious diseases 199 (6), 837-846, 2009 | 884 | 2009 |
| Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization C Puelacher, G Lurati Buse, D Seeberger, L Sazgary, S Marbot, ... Circulation 137 (12), 1221-1232, 2018 | 512 | 2018 |
| Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility C Sur Chowdhury, S Giaglis, UA Walker, A Buser, S Hahn, P Hasler Arthritis research & therapy 16, 1-14, 2014 | 396 | 2014 |
| Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257, 2022 | 388 | 2022 |
| Physiology of iron metabolism S Waldvogel-Abramowski, G Waeber, C Gassner, A Buser, BM Frey, ... Transfusion Medicine and Hemotherapy 41 (3), 213-221, 2014 | 373 | 2014 |
| Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders R Kralovics, SS Teo, S Li, A Theocharides, AS Buser, A Tichelli, ... Blood 108 (4), 1377-1380, 2006 | 348 | 2006 |
| Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease N Cantoni, HH Hirsch, N Khanna, S Gerull, A Buser, C Bucher, J Halter, ... Biology of blood and marrow transplantation 16 (9), 1309-1314, 2010 | 293 | 2010 |
| Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 R Kralovics, SS Teo, AS Buser, M Brutsche, R Tiedt, A Tichelli, ... Blood 106 (10), 3374-3376, 2005 | 262 | 2005 |
| Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders R Kralovics, AS Buser, SS Teo, J Coers, A Tichelli, APC van der Maas, ... Blood 102 (5), 1869-1871, 2003 | 202 | 2003 |
| Use of myeloperoxidase for risk stratification in acute heart failure T Reichlin, T Socrates, P Egli, M Potocki, T Breidthardt, N Arenja, ... Clinical chemistry 56 (6), 944-951, 2010 | 184 | 2010 |
| Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I J Boeddinghaus, T Nestelberger, R Twerenbold, K Wildi, P Badertscher, ... Circulation 135 (17), 1597-1611, 2017 | 178 | 2017 |
| Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray RR De Assis, A Jain, R Nakajima, A Jasinskas, J Felgner, JM Obiero, ... Nature communications 12 (1), 6, 2021 | 176 | 2021 |
| Early diagnosis of myocardial infarction with point-of-care high-sensitivity cardiac troponin I J Boeddinghaus, T Nestelberger, L Koechlin, D Wussler, P Lopez-Ayala, ... Journal of the American college of cardiology 75 (10), 1111-1124, 2020 | 143 | 2020 |
| Effect of definition on incidence and prognosis of type 2 myocardial infarction T Nestelberger, J Boeddinghaus, P Badertscher, R Twerenbold, K Wildi, ... Journal of the American College of Cardiology 70 (13), 1558-1568, 2017 | 142 | 2017 |
| Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction J Boeddinghaus, T Nestelberger, R Twerenbold, JT Neumann, B Lindahl, ... European heart journal 39 (42), 3780-3794, 2018 | 132 | 2018 |
| Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants MT Martinez, CH Bucher, G Stussi, D Heim, A Buser, DA Tsakiris, ... Bone marrow transplantation 36 (11), 993-1000, 2005 | 113 | 2005 |
| Angiogenesis and vascular endothelial growth factor‐/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2‐V617F mutational status M Medinger, R Skoda, A Gratwohl, A Theocharides, A Buser, D Heim, ... British journal of haematology 146 (2), 150-157, 2009 | 111 | 2009 |
| Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms S Stivala, T Codilupi, S Brkic, A Baerenwaldt, N Ghosh, H Hao-Shen, ... The Journal of clinical investigation 129 (4), 1596-1611, 2019 | 104 | 2019 |
| The association of preoperative anemia and perioperative allogeneic blood transfusion with the risk of surgical site infection WP Weber, M Zwahlen, S Reck, H Misteli, R Rosenthal, AS Buser, ... Transfusion 49 (9), 1964-1970, 2009 | 103 | 2009 |
Jakob Passwegbasel universityZweryfikowany adres z usb.ch
